The document is an intimation of a scheduled Investor/Analyst Meet, specifically a one-on-one meeting type.
The meeting is scheduled for Tuesday, 29th September, 2026 with Metlife Investment. The mode of meeting is In-Person.
The stated purpose is for the management of the Company to meet with investors as required under SEBI Listing Regulations.
The company explicitly states that No unpublished price sensitive information (UPSI) will be discussed during this meeting.
Management participants are not specifically listed in this intimation.
The disclosure mentions that this information shall be disclosed on the company's website (www.inoxcva.com) pursuant to regulation 46(2) of the Listing Regulations.
The schedule is noted as being subject to change due to exigencies on the part of either the Investor or the Company.
Additional Notes Section
The document is a regulatory filing submitted to both BSE Limited and the National Stock Exchange of India Ltd.
No financial data, presentation decks, transcripts, or recordings were mentioned as being part of this announcement or planned for availability.
The signatory is Jaymeen Patel, identified as Company Secretary & Compliance Officer, with digital signature verification details provided.
